Magnetic resonance, which exploits the change in energy levels after exposure to a strong magnetic field, forms the basis of some powerful analytical research tools. Magnetic resonance spectroscopy (MRS) encompasses a variety of related techniques, such as nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR), that have a diverse array of research, clinical and industry applications.
The non-invasive, non-destructive nature of the technology allows the study of living cells and tissues as well as detailed analysis of solutions and body fluids. A combination of magnetic resonance analyses can provide both functional information and anatomical information, allowing relationships between the two to be determined.
MRS analysis of urine and blood samples during healthy and diseased states has enabled the identification of biomarkers for assessing the risk of developing a range of conditions as well as predicting treatment response to particular chemotherapies.
Bruker is a leader in the instrument market for magnetic resonance spectrometry, including NMR, time-domain NMR, EPR and preclinical magnetic resonance imaging (MRI).